Lumida
/PLRX
⌘K
Pliant Therapeutics Inc

Pliant Therapeutics Inc

PLRX
$1.17USD+3.54%+0.04 today

MARKET CAP

72.4M

P/E (TTM)

FWD P/E

DAY RANGE

$1 – $1

52W RANGE

$1
$2
STATEMENT·Income statement
USD · GAAP
METRICFY 2020FY 2021FY 2022FY 2023TREND
Sales, Adj.$41.8M$7.6M$9.7M$1.6M
YoY %-81.9%+27.9%-83.7%
P / Sales11.6x63.9x82.4x667.5x
EV / Sales10.7x60.0x82.8x651.9x
Gross Profit, Adj.$41.8M$7.6M$9.7M$1.6M
YoY %-81.9%+27.9%-83.7%
Margin %100.0%100.0%100.0%100.0%
EV / Gross Profit10.7x60.0x82.8x651.9x
EBITDA, Adj.$-40.3M$-96.0M$-125.4M$-182.3M
YoY %-138.0%-30.6%-45.4%
Margin %-96.5%-1267.8%-1294.5%-11538.2%
EV / EBITDA-11.1x-4.7x-6.4x-5.6x
EBIT$-41.6M$-97.5M$-127.2M$-184.1M
YoY %-134.2%-30.4%-44.8%
Margin %-99.6%-1288.1%-1313.4%-11654.7%
EV / EBIT-10.7x-4.7x-6.3x-5.6x
Net Income$-41.5M$-97.3M$-123.3M$-161.3M
YoY %-134.2%-26.8%-30.8%
Net Margin-99.3%-1284.5%-1273.3%-10211.1%
EPS (GAAP)-$1.95-$2.71-$2.94-$2.75
YoY %-39.0%-8.5%+6.5%